chrisvoncsefalvay/vaers-outcomes huggingface dataset:
bad side effects in their muscles, joints and is nauseas; joints; nauseas; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (bad side effects in their muscles, joints and is nauseas), ARTHRALGIA (joints) and NAUSEA (nauseas) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced MYALGIA (bad side effects in their muscles, joints and is nauseas), ARTHRALGIA (joints) and NAUSEA (nauseas). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. At the time of the report, MYALGIA (bad side effects in their muscles, joints and is nauseas), ARTHRALGIA (joints) and NAUSEA (nauseas) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
Flu vaccine given - patient had already received one on 10/13/2022  Moderna Monovalent given - patient has already received Pfizer covid vaccines on 06/30/22, 07/27/2022, 11/02/2022
I took my 17 year old daughter to the pharmacy for her HEP B shot - and she was ACCIDENTIALLY injected with the Moderna COVID vaccine, WHICH WAS INTENDED FOR ANOTHER PATIENT.  This error took place because the pharmacists 'wanted to save time' by bringing syringes for 2 patients into the consultation room.  NOTE: She was already fully vaccinated with the Pfizer vaccine. This was an UNAUTHORIZED 3rd vaccine for which I did not give consent.  My daughter has been ill with vaccine side effects for 3 days. These have included: fever, loss of appetite, nausea, extreme fatigue, muscle pain, joint pain, skin painful to the touch. chills, sore throat, headache. swollen, painful lymph nodes and general malaise. She has also experienced severe anxiety and distress, as have we, as parents.
Shaking; Pain in Arm; Shivering; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR, PAIN IN EXTREMITY (Pain in Arm), and CHILLS in a 50-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TREMOR, PAIN IN EXTREMITY, and CHILLS. At the time of the report, TREMOR, PAIN IN EXTREMITY, and CHILLS outcome was unknown.            No concomitant medication details was reported. No treatment medication details was reported.  Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-091728, MOD-2021-092609.   Most recent FOLLOW-UP information incorporated above included, on 18-Jun-2021 follow-up document contains, No New Information.
Extreme leg pain in injected leg. Pain is so bad he refuses to walk & even being still is painful. Constant crying/whining in pain.
Patient was given Moderna Bivalent dark pink cap 10 microgram/0.2 ml dose as a first dose. This is less than the dose recommended with the change on 4/19/23 of 25 micrograms.
RECONSTITUTED WITH BACTERIOSTATIC SODIUM CHLORIDE 0.9% CUSTOMER DID NOT EXPERIENCE ADVERSE EVENTS.
Patient was given Pfizer orange top for 5-11yrs without diluent. No adverse reactions noted. reported to Dr. and Site supervisor. Dr. looked up vaccine error on CDC website and discovered that no reactions are expected.
ADVERSE EVENT:  BURSITIS OF THE SHOULDER TREATMENT:  4/28/21 CHIROPRACTOR OFFICE VISIT, 5/3/21 CHIRORPACTOR OFFICE VISIT, 5/5/21 CHIROPRACTOR OFFICE VISIT, 5/7 CHIROPRACTOR OFFICE VISIT, 5/8/21 URGENT CARE OFFICE VISIT, 5/14/21 PRIMARY CARE OFFICE VISIT, 5/17/21 CHIROPRACTOR OFFICE VISIT, 5/18/21 ORTHOPEDIC SURGEON OFFICE VISIT, 5/19/21 CHIROPRACTOR OFFICE VISIT, 5/20/21 PHYSICAL THERAPY OFFICE VISIT, 5/24/21 CHIROPACTOR OFFICE VISIT, 5/25/21 PHYSICAL THERAPY OFFICE VISIT, 5/26/21 CHIROPRACTOR OFFICE VISIT, 5/28/21 PHYSICAL THERAPY OFFICE VISIT, 5/31/21 CHIROPRACTOR OFICE VISIT, 6/1/21 PHYSICAL THERAPY OFFICE VISIT, 6/2/21 CHIROPRACTOR OFFICE VISIT, 6/3/21 PHYSICAL THERAPY OFFICE VISIT.  OUTCOME:  UNKNOWN SYMPTOMS: SHOULDER PAIN, BACK MUSCLE/BONE PAIN, CHEST MUSCLE/BONE PAIN, LIMITED MOBILITY.  SYMPTOMS STARTED 4/1/21 AND HAVE PERSISTED THRU TODAY'S DATE.
booster; left sided under arm and injection site pain; left sided under arm and injection site pain; chills; fever; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 41 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 27Dec2021 (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (MANUFACTURER UNKNOWN), for Covid-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 27Dec2021, outcome "unknown", described as "booster"; PAIN IN EXTREMITY (non-serious), VACCINATION SITE PAIN (non-serious) all with onset Dec2021, outcome "not recovered" and all described as "left sided under arm and injection site pain"; CHILLS (non-serious) with onset Dec2021, outcome "not recovered", described as "chills"; PYREXIA (non-serious) with onset Dec2021, outcome "not recovered", described as "fever"; HEADACHE (non-serious) with onset Dec2021, outcome "recovered" (Dec2021), described as "headache". Relevant laboratory tests and procedures are available in the appropriate section. The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient got her period two days after the shot and very heavy.  Her menstrual cycle is generally erratic and heavy, but this was more excessive and longer than usual.
We have 5 patients that received PENTACEL. Out of the 5 patients one patient didn't receive the reconstitute ACTHIB.
I went to a wedding on 1/14/2022 and was exposed to COVID -19. I received a call from a friend 1/17/2022 stating someone at my table tested positive for COVID-19. I woke up on the 19th feeling like I had a sinus infection. I had a sore throat, headache, I felt ran down, I had a cough, and eye pain. I went for a PET scan the same day and was feeling ill more like a sinus infection and was giving a rapid test, PCR, Flu, and strep throat test and it was negative. I developed a fever of 101.7 and my other symptoms lasted for 3-4 days. I lost my taste and smell on 1/22/2022. I experienced some fatigue for an additional week. I have since recovered from all my symptoms.
Headache, nausea, dizziness and bad body aches. Patient reported feeling better on the 3rd day.
Initial information received from another manufacturer (service request number 1-6874826669) on 15 April 2013. The information was originally provided to the other manufacturer by a healthcare professional (pharmacist). A patient, whose age, gender, medical history and concomitant medications were not reported, had received a dose of Rabies vaccine from a unknown manufacturer (batch number, route, dose number and anatomical site of administration were not reported) on an unspecified date in 1999. It was reported that, the patient experienced an allergic reaction to Rabies vaccine in 1999. The corrective treatments and laboratory investigations were not reported. The patient's outcome was recovered. Documents held by sender: none.
covid test result=Positive; covid test result=Positive; This is a spontaneous report from a contactable consumer (patient). A 54-year-old male patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN5318), via an unspecified route of administration in left arm on 26Jan2021 as single dose for Covid-19 immunisation. Medical history included none. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. Prior to vaccination, the patient was not diagnosed with Covid-19. Post vaccination, the patient had been tested for Covid-19. The patient underwent lab tests and procedures which included sars-cov-2 test (Covid test type: nasal swab) positive. There was no treatment received for the adverse events. The outcome of the events was unknown.
Shortly after receiving dose 1 of Moderna covid vaccine patient became sweaty and dizzy. After getting patient to sit down it was found his blood pressure was low at 75/45 then taken again 1 minute later at 98/54.  He started improving after receiving water within 5 minutes of symptom onset.
Received pneumonia vaccine in Lt. arm.  Arm became red and sore.  Saw nurse practitioner who reported severe cellulitis from injection site down to wrist.  Prescribed antibiotics and steriods.  Pt. recovered in a week and doing well.
No adverse reaction. Patient was immunized with Pediarix and also was given a seperate dose of Hepatitis B vaccine.
he can't work; help to the patient walk a few steps; Initial information was received on 15-Dec-2020 regarding an unsolicited valid non-serious social media case from the consumer/non-health care professional.  This case involved an elderly male patient (age was not reported) who could not work (impaired work ability) and needed to help him walk a few steps (gait disturbance), after he received INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), vaccination(s), family history and concomitant medication were not reported.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and other dosing details were not reported) for prophylactic vaccination.  On an unknown date, the patient could not work (impaired work ability) and needed to help him walk a few steps (gait disturbance), (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported that, finally out if hospital and out of rest home. Now in her care help in shower, in bed out of bed, used the restroom took him to physician. He could not work, she served all meals, clean it all up. Help him walk a few steps. This all caused by the wonderful flu shot.   Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome was not reported.  There would be no information available on batch number for this case.
expired dose of Fluzone HD was given on 01Oct2019 inadvertently, no AE; Initial information received on 01-Oct-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves a patient of unknown demography who inadvertently received a expired dose of vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE], on 01-Oct-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error due to expired vaccine used.  At the time of reporting no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
sweaty; heart was pounding really hard; dizzy; arm sore; body aches; fever; headaches; joint aches; very tired; hot; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweaty), PALPITATIONS (heart was pounding really hard), DIZZINESS (dizzy), MYALGIA (arm sore) and MYALGIA (body aches) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure and Alcohol addiction (Patient states he is a beer drinker). Concomitant products included LORAZEPAM for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERHIDROSIS (sweaty), PALPITATIONS (heart was pounding really hard), DIZZINESS (dizzy), MYALGIA (arm sore), MYALGIA (body aches), PYREXIA (fever), HEADACHE (headaches), ARTHRALGIA (joint aches), FATIGUE (very tired) and PYREXIA (hot). At the time of the report, HYPERHIDROSIS (sweaty), PALPITATIONS (heart was pounding really hard), DIZZINESS (dizzy), MYALGIA (arm sore), MYALGIA (body aches), PYREXIA (fever), HEADACHE (headaches), ARTHRALGIA (joint aches), FATIGUE (very tired) and PYREXIA (hot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable. Patient reports taking Tylenol and Advil.
There's a lump in my; It is warm; This case was reported by a consumer via interactive digital media and described the occurrence of mass in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 8th May 2022, the patient received Shingles vaccine. In May 2022, less than a week after receiving Shingles vaccine, the patient experienced mass and skin warm. On an unknown date, the outcome of the mass and skin warm were not recovered/not resolved.   It was unknown if the reporter considered the mass and skin warm to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 9-May-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient received dose of Shingles vaccine yesterday (day before reporting) and now there was a lump in his/her and it was warm. The patient asked was that normal. Additional supportive information: The follow-up would not possible, as no contact, details were available.
First three days arm was just sore; then arm swelled 5-6 inches wide in circle towards elbow-hot red and swollen.
patient received Moderna dose 2 instead of Pfizer dose 2, pt made aware of error
pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 12Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (hospitalization) with onset 2021, outcome "unknown", described as "pain". The patient was hospitalized for pain (start date: 2021). Therapeutic measures were taken as a result of pain. Clinical course: It was reported that the patient was just in the hospital and was taking 2 different antibiotics as pain killers. She wanted to known if she should get the 2nd dose tomorrow.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient had swollen arm size of 3 inches across w/emanating heat & itching. She put ice on it and took BENADRYL tablets and swelling went down next day considerably.
I started to have weakness with prolonged coughing. I had muscle and joint soreness. I was generally feeling not normal. I had symptoms for about a week. I completed a home test and it was positive. I don't recall when I completed the home test. I went to the walk in clinic and they prescribed the medication. All of my symptoms started to go away except the consistent cough. I feel ok other than that.
Swelling and erythema at injection site for 1 week, then dry scaling (approximately 15cm).
Developed GI problems after the second dose of the Moderna COVID-19 vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of ABDOMINAL DISCOMFORT (Developed GI problems after the second dose of the Moderna COVID-19 vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (Developed GI problems after the second dose of the Moderna COVID-19 vaccine). At the time of the report, ABDOMINAL DISCOMFORT (Developed GI problems after the second dose of the Moderna COVID-19 vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
I had a crazy rash over my whole body - very very itchy; spots. They gave me Prednisone. That took care of it - they are mostly gone. The dermatologist has given me cream that seems to help. Not completely better yet.
This is a spontaneous report from a contactable consumer (patient). A 77-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EL9269), via intramuscular route, administered in Arm Left on 09Feb2021 10:30 as 1ST DOSE, SINGLE for COVID-19 immunization. The patient was 77-years-old at the time of vaccination. Time the vaccination was given was 10:30. The patient medical history included diabetes from 2012 to an unknown date, high blood pressure from 2012 to an unknown date and thyroid problems. Family medical history: All of family have high blood pressure and thyroid problems, thyroid surgery on 2012. No concomitant medications prior to Vaccinations (within 4 weeks). On 11Feb2021, Patient reported that she felt that there was lots of gas in her stomach after she had the 1st dose - She described it that there are lots of gases in her stomach and once she goes to the bathroom it suddenly disappears. She never had gas like this. The gas fell down in her stomach all of a sudden. If she has gas, she takes pills or something. This is like more progressive. She doesn't hardly have any irritation in bottom of stomach. She never had it. She would like to know if her stomach problems are a side effect from the vaccine. No relevant test. Events were assessed as non-serious. The outcome of event was not recovered. Follow-up (11May2021): Follow-up attempts completed. No further information expected.
Initial unsolicited case received from a physician on 19 Sep 2017. This case involves 80-year-old male patient who was vaccinated with 0.5 ml one dose of FLUZONE QUADRIVALENT (Batch number, expiry date, dose in series and site of administration were not reported) via intramuscularly on 13 Sep 2017. Patient medical history and concomitant medications were not reported. On an unknown date, three days after the vaccination, the patient developed urticaria and edema at the left deltoid and a widespread rash over his body. Rash was red and itchy. The patient was seen by the MD and a course of steroids was prescribed. Relevant lab tests and other corrective treatment were not reported. The outcome of all the events were reported as recovering. List of documents held by sender: none.
temperature intolerance; tinnitus; exercise intolerance; disruption in my sleep schedule; This spontaneous case was reported by an other health care professional and describes the occurrence of TEMPERATURE INTOLERANCE (temperature intolerance), TINNITUS (tinnitus), EXERCISE TOLERANCE DECREASED (exercise intolerance) and SLEEP DISORDER (disruption in my sleep schedule) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     It was reported that patient had absolutely no underlying issues.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TEMPERATURE INTOLERANCE (temperature intolerance), TINNITUS (tinnitus), EXERCISE TOLERANCE DECREASED (exercise intolerance) and SLEEP DISORDER (disruption in my sleep schedule). At the time of the report, TEMPERATURE INTOLERANCE (temperature intolerance), TINNITUS (tinnitus), EXERCISE TOLERANCE DECREASED (exercise intolerance) and SLEEP DISORDER (disruption in my sleep schedule) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported.  Patient had received second Moderna vaccine and within about two weeks, patient immediately had temperature intolerance, tinnitus,exercise intolerance and with the disruption in my sleep schedule.  Patient assumed all of this was due to stress and tried to kind of move on with patient's life last year continuing to work and sitting on board seats as patient had done previously in late Dec 2021.  No treatment medication were reported.   This case was linked to MOD-2022-592801 (Patient Link).
7x5 cm macular erythematous lesion on arm (still present); swelling of eyelids, discomfort in eyes 2OCT91; resolved 3OCT91;
Palm of hand turned glowing yellowish gold, Gold streaks in palm, hand looked very different; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (Palm of hand turned glowing yellowish gold, Gold streaks in palm, hand looked very different) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and ROSUVASTATIN for an unknown indication.    On 25-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced SKIN DISCOLOURATION (Palm of hand turned glowing yellowish gold, Gold streaks in palm, hand looked very different). On 25-Jan-2021, SKIN DISCOLOURATION (Palm of hand turned glowing yellowish gold, Gold streaks in palm, hand looked very different) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. The patient noticed he had gold streaks in his hand later the next night. The patient strongly believed the condition was caused by something completely different.   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: Event details updated.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.